NCT05456620

Brief Summary

Insertional Achilles tendinopathy is a disabling injury that is common in running athletes. Exercise therapy is considered the best treatment option, but there is still no agreement on the modalities. For example, it is thought that compression overload may be a major cause of tendinopathy and should therefore be restricted during rehabilitation. However, this recommendation is based on expert opinion and not on hard scientific evidence. Therefore, this randomised controlled trial (RCT) will investigate whether a therapy that limits the amount of compression of the tendon during a progressive tendon-loading rehabilitation protocol actually has better outcomes in athletes with insertional Achilles tendinopathy. Athletes with insertional Achilles tendinopathy will be randomised into two treatment groups; (1) an experimental rehabilitation protocol in which the amount of tendon compression is limited and (2) a control rehabilitation protocol in which the amount of tendon compression is not limited and is rather high. Both treatments consist of supervised progressive tendon-loading exercise therapy and patient education. In addition, the experimental group will also receive heel inserts to limit the amount of dorsiflexion during sports or daily activities. At baseline, at 12 weeks (end of intervention) and at 24 weeks (follow-up), pain, functionality, structure and intratendinous pressure will be determined.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

December 5, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2024

Completed
Last Updated

August 7, 2024

Status Verified

August 1, 2024

Enrollment Period

1.7 years

First QC Date

July 7, 2022

Last Update Submit

August 5, 2024

Conditions

Keywords

Exercise therapyTendon compressionTendinopathy

Outcome Measures

Primary Outcomes (2)

  • The change of the Victorian Institute of Sports Assessment-Achilles Questionnaire (VISA-A) score over 12 weeks

    The VISA-A score is a measure of pain and lower limb function (disability) associated with Achilles tendinopathy. A higher score indicates a better outcome and a 10 point increase is accepted as being clinically meaningful.

    12 weeks (at the end of intervention)

  • The change of the Victorian Institute of Sports Assessment-Achilles Questionnaire (VISA-A) score over 24 weeks

    The VISA-A score is a measure of pain and lower limb function (disability) associated with Achilles tendinopathy. A higher score indicates a better outcome and a 10 point increase is accepted as being clinically meaningful.

    24 weeks (at follow-up)

Secondary Outcomes (13)

  • Subjective patient satisfaction

    This will be assessed at the end of the intervention (week 12) and at follow-up (week 24).

  • Return to sports rate

    This will be assessed at the end of the intervention (week 12) and at follow-up (week 24).

  • Hop test

    This will be assessed at the start (week 0), at the end of the intervention (week 12) and at follow-up (week 24).

  • Lower Extremity Functional Scale

    This will be assessed at the start (week 0), at the end of the intervention (week 12) and at follow-up (week 24).

  • Tampa scale for kinesiophobia (TSK)

    This will be assessed at the start (week 0), at the end of the intervention (week 12) and at follow-up (week 24).

  • +8 more secondary outcomes

Other Outcomes (2)

  • Ultrasound examination to assess presence of rectrocalcaneal bursitis and/or intratendinous calcifications

    This will be assessed at baseline (week 0)

  • X-ray to assess presence of Haglund's deformity

    This will be assessed at baseline (week 0)

Study Arms (2)

Low Tendon Compression Rehabilitation (LTCR)

EXPERIMENTAL

A progressive, criteria-based, 4-stage exercise protocol in which the amount of tendon compression is limited (12 weeks).

Other: Exercise therapy

High Tendon Compression Rehabilitation (HTCR)

ACTIVE COMPARATOR

A progressive, criteria-based, 4-stage exercise protocol in which the amount of tendon compression is not limited (12 weeks).

Other: Exercise therapy (usual care)

Interventions

The intervention treatment consists of a progressive 4-stage, criteria-based exercise protocol, in which the amount of tendon compression is limited. This includes: 1. Education: Specific information on the importance of limiting tendon compression during rehabilitation, as well as general information on load management, the importance of active exercise therapy and setting expectations. 2. Orthotic treatment: heel inserts to reduce ankle dorsiflexion during daily activities and sports 3. Physiotherapy: Progressive tendon-loading exercise therapy (4 phases) restricting the amount of tendon compression by limiting dorsiflexion of the ankle and prohibiting stretching

Low Tendon Compression Rehabilitation (LTCR)

The control treatment consists of a progressive 4-phase, criteria-based exercise protocol, in which the amount of tendon compression is not limited. This includes: 1. Education: general information on load management, the importance of active exercise therapy and setting expectations. 2. No orthotic treatment. 3. Physiotherapy: Progressive tendon-loading exercise therapy (4 phases) without any restriction around tendon compression and encouraging stretching

High Tendon Compression Rehabilitation (HTCR)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-60 years old
  • Diagnosed with insertional Achilles Tendinopathy by a sports medicine physician
  • Have experienced symptoms for more than 3 months but less than 3 years
  • A severity level of less than 80 points on the VISA-A score
  • Playing running-based sports at least twice a week
  • Able to comply with both exercise programs

You may not qualify if:

  • Have a history of Achilles tendon rupture or surgery
  • Have other disorders of the Achilles tendon or ankle (mid-portional Achilles tendinopathy, paratenonitis, osteoarthritis,...)
  • Have rheumatological disorder (e.g. Spondylitis Ankylosis)
  • Have metabolic or endocrine disorders, such as type I or type II diabetes
  • Have had an Achilles injection in the past 3 months
  • Have other conditions that prevent following an active exercise programme
  • Have already been treated with physiotherapy, shockwave therapy or orthotics in the past 3 months
  • Medication use with (fluoro)quinolones antibiotic in the past 2 years
  • Currently pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of rehabilitation sciences

Ghent, 9000, Belgium

Location

Related Publications (1)

  • Pringels L, Capelleman R, Van den Abeele A, Burssens A, Planckaert G, Wezenbeek E, Vanden Bossche L. Effectiveness of reducing tendon compression in the rehabilitation of insertional Achilles tendinopathy: a randomised clinical trial. Br J Sports Med. 2025 Apr 24;59(9):640-650. doi: 10.1136/bjsports-2024-109138.

MeSH Terms

Conditions

Tendinopathy

Interventions

Exercise Therapy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

RehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Luc Vanden Bossche

    Department of Rehabilitation Sciences, Ghent University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The principal investigator (LP) will be blinded to the assigned treatment throughout the data collection period. During the study, patients will be asked not to discuss their treatment exercises with the principal investigator but to consult an independent second sports physician (AB) if they have any questions about the therapy.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2022

First Posted

July 13, 2022

Study Start

December 5, 2022

Primary Completion

August 1, 2024

Study Completion

August 1, 2024

Last Updated

August 7, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations